About Bioscan

Bioscan is a leading developer of advanced instrumentation for the detection, synthesis, and imaging of Radiolabeled Compounds used in four areas…

  • Life Science Research
  • Molecular Imaging
  • Pharmaceutical Development
  • Nuclear Medicine

 

History:

Founded in 1980, Bioscan has supplied customers with unique research productivity tools for more than 25 years. 

Thousands of customers worldwide--in universities, research hospitals, government laboratories, and pharmaceutical companies--use Bioscan products for basic biomedical research…and for the production of radiopharmaceuticals.

With the introduction of its NanoSPECT/CT in vivo imaging system in 2006, Bioscan sets a new standard in the field of molecular imaging of animal models for biological & disease research.

 

Mission Statement:

Bioscan facilitates early disease diagnosis--and accelerates drug discovery--by providing innovative technologies for bio-tracer chemistry and preclinical imaging. Our goal is to provide researchers with reliable, flexible, and easy-to-use instrumentation that offers state-of-the-art performance capabilities.

 

Our Business:

Bioscan is a leading provider of SPECT (Single Photon Emission Computed Tomography) and PET (Positron Emission Tomography) imaging systems for preclinical applications. Our tools enable researchers, pharmaceutical and biotech organizations to improve their drug development research using in vivo animal models.

Preclinical imaging uses molecular biomarkers in small animals to conduct in vivo methods by providing more relevant biological data, more consistency, as well as reduced cost and complexity. Our patented technology improves screening of drug pipeline candidates over classic in vitro methods by providing more relevant biological data, more consistency, as well as reduced cost and complexity. The unique imaging acuity of our products also makes it possible to translate research results from mouse models of human diseases to human clinical trials – driving increased speed to market for drugs.

Bioscan is also a supplier of innovative instruments for radioisotope detection and analysis in life science, pharmaceutical and nuclear medicine research applications. As an expansion of its involvement in nuclear medicine, Bioscan now provides a variety of automated synthesis modules for the production of PET (F-18 & C-11) radiopharmaceuticals. Our analytical instruments provide solutions to both chemical purity and quality control in many applications involving radio-TLC, radio-HPLC, and isotope detection.